CLINICAL_TRIALS
trial_result
· 2020-09-25
Clinical Trial Update: Multicenter Study to Evaluate the Effect of BTI320 on Glycemic Control in Type 2 Diabetes [Phase 2]
Summary
Phase 2 multicenter study evaluating BTI320 for glycemic control in type 2 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boston Therapeutics | Conditions: Type2 Diabetes Mellitus | Phase 2 | Status: COMPLETED